April 21

INTERPHEX Presentation: The Road to the Biologic IND

Presenter: Michiel Ultee • Principal Consultant, Ulteemit BioConsulting, LLC Location: INTERPHEX Innovation Stage 2, Exhibit Hall The Biologic IND (Investigational New Drug) application is a critical, early milestone in evaluating the safety and efficacy of a potential new biopharmaceutical. An approved IND allows a sponsoring company to take the next step in developing its product.